Schering will be coming out with a second generation (Claritin) drug in the next few months, so it depends how many people they convert (to the new drug), ... They could be in Merck's shoes a few quarters from now, but I don't think they have the visibility to say.
Quotes about schering (3 Quotes)
The proposed takeover of Schering is in line with our strategic objective to further grow our health care business, especially in the area of pharmaceutical specialty products.
It makes sense because both Merck and Schering are too small to compete. Sentiment is good for mergers and acquisitions at the moment.